
The study investigated pathogenic germline variants in mucosal melanoma (MM) patients enrolled in the Gross Family Melanoma Registry. The results show a high prevalence of germline mutations (50%) associated with melanoma and general cancer susceptibility, with CHEK2 and APC variants identified in 12.5% of cases each. The findings suggest that germline-driven cancer susceptibility plays a significant role in MM, surpassing the 15% prevalence found in cutaneous melanoma.
Like
Save
Share